U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown

Jan.11.2025
U.S. Agencies Seize Over $7 Million in Illegal E-Cigarettes as FDA Pledges Continued Crackdown
The Miami operation, announced on January 10, is the latest joint effort by multiple U.S. federal agencies to combat illegal e-cigarettes, resulting in the seizure of over $7 million worth of unauthorized products. The FDA emphasized that an “All Government” approach is critical in addressing the issue of illegal e-cigarettes.

Key Points:

 

1. This is another significant enforcement action following the October 2024 seizure of $76 million worth of illegal e-cigarettes.

 

2. Recently, the FDA has issued a series of announcements, including the January 3 announcement regarding updates to import alerts, allowing all unauthorized e-cigarettes to be detained without physical examination. These actions signal an acceleration of the FDA’s crackdown on illegal e-cigarettes.

 

3. In this announcement, Geek Bar was once again the only brand explicitly named, with the FDA stating that it “may appeal to youth.” This underscores the FDA’s close attention to the brand.

 

4. The details disclosed in this announcement—such as the seizure in Miami and the methods by which illegal products entered the U.S.—demonstrate the increasing precision and efficiency of enforcement under multi-agency cooperation.

 

5. The head of the FDA’s Center for Tobacco Products emphasized the importance of the “All Government” approach, in combating illegal e-cigarettes. This suggests that additional cases of illegal e-cigarette seizures may occur in the future.

 

 

 

[January 10, 2025] U.S. federal agencies announced the seizure of more than 628,000 unauthorized e-cigarette products from a warehouse in Miami, with a retail value exceeding $7 million. The confiscated items included flavored disposable e-cigarettes, kits, and batteries, with some products from brands like Geek Bar, which are known to appeal to youth.

 

The operation, led by U.S. Customs and Border Protection (CBP), uncovered shipments of illegal e-cigarette products originating from China and destined for various U.S. states. Investigations revealed that these products were intentionally misdeclared and undervalued—common tactics to evade detection and duties. Following referrals to the FDA’s Center for Tobacco Products, authorities confirmed the products lacked mandatory premarket authorization, rendering them illegal for sale or distribution in the U.S.

 

“An ‘All Government’ approach is critical to preventing unauthorized e-cigarettes from entering the United States” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Today’s action is another step in the right direction, and we remain committed to continuing to work with our federal partners to continue to combat the entry of these illegal products head on.”

 

Confiscated products, like those seized in this operation, are typically disposed of in compliance with federal regulations. For unauthorized tobacco products, including e-cigarettes, this generally means destruction.

 

The Miami operation is part of an intensified federal crackdown on illegal e-cigarette distribution. It follows a $76 million seizure of unauthorized e-cigarettes in October 2024 and builds on efforts spearheaded by a federal task force established in June 2024 to streamline enforcement. These coordinated actions aim to hold violators accountable by leveraging criminal and civil tools across multiple agencies.

 

To date, the FDA has authorized only 34 e-cigarette products and devices for legal sale in the U.S. More information on authorized tobacco products can be found in the FDA’s Searchable Tobacco Products Database.

 

Original FDA Announcement : Over $7 Million Worth of Illegal E-Cigarettes Seized in Federal Operation

 

 

 

2Firsts Editorial Note:

 

Since the second half of 2024, U.S. agencies have continued their crackdown on illegal e-cigarettes. Through coordinated efforts across multiple federal departments, these enforcement actions have achieved increasingly significant results, reflecting the U.S. federal government’s determination and strategic optimization in combating illegal e-cigarettes.

 

2Firsts has been closely monitoring U.S. regulatory actions on e-cigarettes. At the recently concluded 2Firsts 2024 Global NGP Compliance Development Symposium, 2Firsts invited several U.S. compliance experts to provide detailed insights into U.S. compliance policies for e-cigarette companies. Additionally, in 2Firsts’ 2024 Global Top 10 NGP News, the story titled “1. U.S. E-Cigarette Regulations Intensify, Setting the Stage for a Major Market Shakeup” ranked first.

 

 

 

Recent 2Firsts reports on U.S. regulations include:

 

1.FDA Strengthens Import Alerts to Address Unauthorized E-Cigarettes Detention

 

2.FDA Warns 9 Online Firms for Illegally Selling Flavored, Disposable E-Cigarettes, Including Geek Bar and Lost Mary

 

3.FDA Outlines Recent Regulatory Actions to 2Firsts: Comprehensive Oversight and Strategies Adapting to Market Changes


4.U.S. FDA's 2024 Illicit E-Cigarette Crackdown: Full-Spectrum Enforcement and Targeted Actions Against Geekvape and Heaven Gifts

 

5.FDA, CBP seize 3 million illegal e-cigarette products worth $76 million, including GEEKBAR

 

6.U.S. Regulatory Storm to Drive Profound Changes in China's E-Cigarette Supply Chain, Says Alan Zhao, CEO of 2Firsts

 


 

2Firsts welcomes article submissions, interview opportunities, or commentary. Please contact us at info@2firsts.com or connect with 2Firsts CEO Alan Zhao on LinkedIn here.

 

Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives